功能丧失的Gαs罕见疾病变体对GPCR信号传递产生突变特异性影响
Theo Redfern-Nichols1, Shannon L O'Brien2,3, Xianglin Huang1
1Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK.
Science signaling
|May 20, 2025
概括
与类型 Ic 伪偏偏甲状腺症相关的突变 Gαs 蛋白质 (L388R 和 E392K) 不同地破坏 G 蛋白结合受体 (GPCR) 信号传递. 了解这些特定的Gαs突变是开发针对这种罕见疾病的向治疗的关键.
科学领域:
- 分子生物学分子生物学
- 生物化学 生物化学
- 遗传学 是一个遗传学.
背景情况:
- G蛋白结合受体 (GPCR) 检测出细胞外信号,激活G蛋白进行细胞内反应.
- Gαs蛋白对GPCR信号传递至关重要,其突变可以影响多个受体.
- 伪低甲状腺症类型Ic (PHPIc) 是一种罕见的,与特定Gαs突变相关的母亲遗传性疾病.
研究的目的:
- 研究与PHPIc相关的两个Gαs突变 (L388R和E392K) 如何影响GPCR信号传递,特别是在脏中.
- 为了了解由基因印记引起的Gαs突变对特定组织的影响.
主要方法:
- 3D结构的综合分析,GPCR-G蛋白合特异性,转录学,生物物理学和分子动力学.
- 系统药理学建模被用来预测改变的GPCR信号.
- 通过甲状腺激素受体1 (PTH1R) 对Gαs突变体的G蛋白激活的具体分析.
主要成果:
- 鉴定了GPCRs,其信号由中的Gαs突变改变.
- 这种L388R Gαs突变导致与PTH1R的相互作用受损.
- 该E392K Gαs突变减少了PTH1R诱导的异构三基Gs蛋白的激活.
结论:
- 不同的Gαs突变可以破坏GPCR信号转导中的不同步骤.
- 研究突变特异性影响对于PHPIc中个性化治疗策略至关重要.
- 这项研究为分析GPCR信号多样性在各种生物环境中的分析提供了一个框架.
相关概念视频
Activation and Inactivation of G Proteins
6.8K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
6.8K
G Protein-coupled Receptors
11.5K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.5K
Transducer Mechanism: G Protein–Coupled Receptors
1.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.9K
GPCR Desensitization
5.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.9K
GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
Amplifying Signals via Enzymatic Cascade
8.4K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.4K


